Garland Capital Management Inc Johnson & Johnson Transaction History

Garland Capital Management Inc

$130 Million
Q3 2024

A detailed history of Garland Capital Management Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Garland Capital Management Inc holds 28,447 shares of JNJ stock, worth $4.41 Million. This represents 3.54% of its overall portfolio holdings.

Number of Shares

28,447

Previous 32,732 13.09%

Holding current value

$4.41 Million

Previous $4.78 Million 3.64%

% of portfolio

3.54%

Previous 3.38%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$145.48 - $167.38 $623,381 - $717,223	-4,285 Reduced 13.09%	28,447 $4.61 Million
Q2 2024 Jul 30, 2024	SELL	$144.38 - $157.78 $46,201 - $50,489	-320 Reduced 0.97%	32,732 $4.78 Million
Q1 2024 Apr 30, 2024	SELL	$155.22 - $162.74 $23,283 - $24,411	-150 Reduced 0.45%	33,052 $5.23 Million
Q4 2023 Jan 29, 2024	SELL	$145.6 - $158.88 $250,432 - $273,273	-1,720 Reduced 4.93%	33,202 $5.2 Million
Q3 2023 Oct 31, 2023	SELL	$155.75 - $174.48 $26,789 - $30,010	-172 Reduced 0.49%	34,922 $5.44 Million
Q2 2023 Jul 20, 2023	SELL	$154.35 - $166.11 $181,361 - $195,179	-1,175 Reduced 3.24%	35,094 $5.81 Million
Q1 2023 Apr 25, 2023	BUY	$151.05 - $180.26 $83,077 - $99,143	550 Added 1.54%	36,269 $5.62 Million
Q4 2022 Jan 19, 2023	BUY	$160.2 - $179.79 $14,417 - $16,181	90 Added 0.25%	35,719 $0
Q3 2022 Oct 20, 2022	BUY	$161.33 - $179.52 $39,525 - $43,982	245 Added 0.69%	35,629 $5.82 Million
Q2 2022 Jul 20, 2022	SELL	$168.19 - $186.01 $117,733 - $130,207	-700 Reduced 1.94%	35,384 $6.28 Million
Q1 2022 Apr 27, 2022	BUY	$158.14 - $179.59 $3,479 - $3,950	22 Added 0.06%	36,084 $6.4 Million
Q4 2021 Feb 03, 2022	SELL	$155.93 - $173.01 $389,825 - $432,525	-2,500 Reduced 6.48%	36,062 $6.17 Million
Q3 2021 Oct 27, 2021	SELL	$161.5 - $179.47 $16,150 - $17,947	-100 Reduced 0.26%	38,562 $6.23 Million
Q2 2021 Jul 27, 2021	SELL	$159.48 - $171.07 $63,791 - $68,428	-400 Reduced 1.02%	38,662 $6.37 Million
Q1 2021 Apr 21, 2021	SELL	$153.07 - $170.48 $15,307 - $17,048	-100 Reduced 0.26%	39,062 $6.42 Million
Q4 2020 Feb 09, 2021	BUY	$137.11 - $157.38 $13,711 - $15,738	100 Added 0.26%	39,162 $6.16 Million
Q3 2020 Apr 21, 2021	SELL	$140.38 - $153.83 $7.27 Million - $7.97 Million	-51,812 Reduced 57.02%	39,062 $5.82 Million
Q3 2020 Oct 22, 2020	BUY	$140.38 - $153.83 $7.25 Million - $7.94 Million	51,637 Added 131.6%	90,874 $13.5 Million
Q2 2020 Jul 24, 2020	SELL	$128.81 - $155.51 $164,232 - $198,275	-1,275 Reduced 3.15%	39,237 $5.52 Million
Q1 2020 Apr 13, 2020	SELL	$111.14 - $153.99 $22,228 - $30,798	-200 Reduced 0.49%	40,512 $5.31 Million
Q3 2019 Oct 10, 2019	SELL	$126.95 - $142.14 $37,450 - $41,931	-295 Reduced 0.72%	40,712 $5.27 Million
Q2 2019 Jul 24, 2019	SELL	$131.15 - $144.24 $16,393 - $18,030	-125 Reduced 0.3%	41,007 $5.71 Million
Q1 2019 Apr 18, 2019	SELL	$125.72 - $139.79 $40,859 - $45,431	-325 Reduced 0.78%	41,132 $5.75 Million
Q4 2018 Jan 24, 2019	BUY	$122.84 - $147.84 $6,142 - $7,392	50 Added 0.12%	41,457 $5.35 Million
Q3 2018 Mar 12, 2019	SELL	$121.58 - $142.88 $137,385 - $161,454	-1,130 Reduced 2.66%	41,407 $5.72 Million
Q2 2018 Jul 13, 2018	SELL	$119.4 - $131.76 $62,685 - $69,174	-525 Reduced 1.22%	42,537 $5.16 Million
Q1 2018 Apr 24, 2018	BUY	$125.1 - $148.14 $68,805 - $81,476	550 Added 1.29%	43,062 $5.52 Million
Q4 2017 Jan 25, 2018	SELL	$131.22 - $143.62 $769,998 - $842,762	-5,868 Reduced 12.13%	42,512 $5.94 Million
Q3 2017 Nov 09, 2017	BUY	$129.47 - $135.38 $6.26 Million - $6.55 Million	48,380	48,380 $6.29 Million

Others Institutions Holding JNJ

# of Institutions

4,271

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Garland Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Garland Capital Management Inc with notifications on news.

Account

Garland Capital Management Inc Johnson & Johnson Transaction History